Therapeutics Area Partnerships (TAP) is the industry's newest specialized biopharmaceutical partnering event series, aligning the most prominent professionals in their respective therapeutic areas to connect to share expertise, engage in meaningful connections to drive business forward, and answer questions for the most pressing challenges faced. A uniquely efficient platform, TAP brings together decision-makers to assess the most promising drug programs available for partnering in their respective therapeutic areas:

• Oncology
• Cardiology
• Neuroscience
• Infectious Diseases
• Anti-Inflammatory/Autoimmune Diseases
• Advanced Therapies (Cellular and Gene Therapies, Rare Diseases and other high value and niche areas)